U.S. Congress - S.3187 Synthetic Drug Abuse Prevention Act of 2012
S.3187 - Synthetic Drug Abuse Prevention Act of 2012
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (24)
All Bill Titles
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
- Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
- Short: Medical Device User Fee Amendments of 2012 as passed senate.
- Short: Generic Drug User Fee Amendments of 2012 as passed senate.
- Short: Biosimilar User Fee Act of 2012 as passed senate.
- Short: Food and Drug Administration Safety and Innovation Act as passed senate.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Safety and Innovation Act as passed house.
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as enacted.
- Short: Biosimilar User Fee Act of 2012 as enacted.
- Short: Generic Drug User Fee Amendments of 2012 as enacted.
- Short: Medical Device User Fee Amendments of 2012 as enacted.
- Short: Prescription Drug User Fee Amendments of 2012 as enacted.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| Latest Amendment | Status | Purpose View All Amendments [47] |
|---|---|---|
| S.Amdt.2107 | Offered | To allow the importation by individuals of safe and affordable drugs from Canada. |
| S.Amdt.2108 | Offered | To prohibit approval by the Food and Drug Administration of genetically engineered fish unless the National Oceanic and Atmospheric Administration concurs with such approval. |
| S.Amdt.2109 | Offered | To revoke the exclusivity of certain entities that are responsible for violations of the Federal Food, Drug, and Cosmetic Act, the False Claims Act, and other certain laws. |
| Latest Actions View All Actions [36] | |
|---|---|
| May 15th | |
| May 15th | Introduced in the Senate. Read the first time. Placed on Senate Legislative Calendar under Read the First Time. |
| May 16th | Read the second time. Placed on Senate Legislative Calendar under General Orders. Calendar No. 400. |
Latest Vote
Result: Motion Agreed to - June 26, 2012
Roll call number 168 in the Senate
Question: On the Motion (Motion to Concur in the House Amendment to Accompany S. 3187)
Required percentage of 'Aye' votes: 1/2 (50%)
Percentage of 'aye' votes:
92%
Vote on This Bill
-
Share This Bill
More Share via Email
